Company · Ownership research

Neumora Therapeutics, Inc. NMRA

CIK 0001885522

Form 4 transactions dated Nov 1, 2023 to Nov 7, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 158 rows; the complete set is available through the API.

Insider filings on file run through Aug 21, 2026.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $21.11M
Sold: $3.77M

Nov 1, 2023 – Aug 21, 2026
Available records · partial months are marked ·

Insiders in this window

20259 of 9 preview events

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 11, 2025	Aurora Daljit Singh See Remarks	Sale10b5-1 footnote	$307.03K 114,703 shares sold	100.00% sold Indirect holding	▾
Oct 27, 2025	Burow Kristina Director · 10% owner	Purchase	$5.00M 1,915,700 shares bought	46.37% added Indirect holding	▾
Oct 27, 2025	CRANDELL KEITH · NELSEN ROBERT · BYBEE CLINTON · GILLIS STEVEN · ARCH Venture Fund XII, L.P. · ARCH Venture Partners XII, LLC · ARCH Venture Partners XII, L.P. 10% owner	Purchase	$5.00M 1,915,700 shares bought	Unavailable Indirect holding	▾
Oct 27, 2025	ARCH Venture Fund VII, L.P. · ARCH Venture Partners VII, LLC · ARCH Venture Partners VII, L.P. · ARCH Venture Partners VIII, LLC · ARCH Venture Fund VIII Overage, L.P. · ARCH Venture Fund X, L.P. · ARCH Venture Fund X Overage, L.P. · ARCH Venture Partners X Overage, L.P. · ARCH Venture Partners X, LLC · ARCH Venture Partners X, L.P. 10% owner	Purchase	$5.00M 1,915,700 shares bought	Unavailable Indirect holding	▾
Feb 18, 2025	BERNS PAUL L See Remarks · Director	Sale10b5-1 footnote	$23.47K 13,871 shares sold	0.19% sold Direct holding	▾
Feb 18, 2025	Milligan Michael Lee See Remarks	Sale10b5-1 footnote	$3.35K 1,978 shares sold	8.09% sold Direct holding	▾
Feb 18, 2025	Aurora Daljit Singh Chief Strategy Officer	Sale10b5-1 footnote	$14.35K 8,565 shares sold	8.78% sold Direct holding	▾
Feb 18, 2025	Lenz Robert A. Head of R&D	Sale10b5-1 footnote	$9.38K 5,614 shares sold	1.78% sold Direct holding	▾
Feb 18, 2025	Pinto Joshua President	Sale10b5-1 footnote	$13.48K 8,048 shares sold	9.47% sold Direct holding	▾

Showing 9 / 9 record groups in 2025. The complete set is available through the API.

Neumora Therapeutics, Inc. · NMRA

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 9 of 9 purchase / sale groups and 30 of 158 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"NMRA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.